News
Johnson, whose father, Lucas, played basketball for Illinois, is drawing offers in basketball and interest in volleyball.
AbbVie has placed a high price on that potential, coughing up $700 million for a phase 1 candidate and offering up to $1.225 ...
Other NFL team previews: 32. Titans | 31. Saints | 30. Browns | 29. Panthers | 28. Jets | 27. Giants | 26. Raiders | 25. Patriots | 24. Colts | 23. Dolphins | 22. Jaguars | 21. Falcons | 20. Steelers ...
The father of the Chicago drill rapper whose album release party was targeted in a mass shooting in River North over the Fourth of July has been hit with federal weapons charges alleging he sold 13 ...
A decades-old rule keeping churches from endorsing politicians was struck down in court. Here's what to know about the Johnson Amendment.
Johnson & Johnson's 2025 outlook sees slight EPS and revenue upgrades, while headwinds from biosimilars and tariffs are ...
JNJ which has outperformed the S&P 500 and other large-cap healthcare peers in H1-2025, now faces a crucial test with Q2 ...
1d
Zacks Investment Research on MSNJohnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Should You Buy?Wall Street expects a year-over-year decline in earnings on higher revenues when Johnson & Johnson (JNJ) reports results for ...
J&J(JNJ) wins U.S. appeals court case protecting its Invega Sustenna patent from generic rivals Viatris (VTRS) & Teva (TEVA).
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On July 3, Janssen-Cilag, a ...
Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to ...
Johnson & Johnson has asked a federal judge in Central California for a judgment as a matter of law to throw out a jury's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results